The global market for Patent Drug was valued at US$ 1175150 million in the year 2024 and is projected to reach a revised size of US$ 1645690 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Patent Drug Market

A patent medicine is typically protected and advertised by a trademark and trade name (and sometimes a patent) and claimed to be effective against minor disorders and symptoms.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Patent Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Patent Drug.

The Patent Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Patent Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Patent Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Patent Drug Market Report

Report Metric	Details
Report Name	Patent Drug Market
Accounted market size in year	US$ 1175150 million
Forecasted market size in 2031	US$ 1645690 million
CAGR	5.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Oral Injection Other
Segment by Application	Hospital Retail Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences, GlaxoSmithKline (GSK), Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Teva, Bayer, Novo Nordisk, Takeda, Boehringer Ingelheim
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Patent Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Patent Drug Market growing?

Ans: The Patent Drug Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Patent Drug Market size in 2031?

Ans: The Patent Drug Market size in 2031 will be US$ 1645690 million.

Who are the main players in the Patent Drug Market report?

Ans: The main players in the Patent Drug Market are Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences, GlaxoSmithKline (GSK), Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Teva, Bayer, Novo Nordisk, Takeda, Boehringer Ingelheim

What are the Application segmentation covered in the Patent Drug Market report?

Ans: The Applications covered in the Patent Drug Market report are Hospital, Retail Pharmacy

What are the Type segmentation covered in the Patent Drug Market report?

Ans: The Types covered in the Patent Drug Market report are Oral, Injection, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Patent Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Oral

1.2.3 Injection

1.2.4 Other

1.3 Market by Application

1.3.1 Global Patent Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Patent Drug Market Perspective (2020-2031)

2.2 Global Patent Drug Growth Trends by Region

2.2.1 Global Patent Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Patent Drug Historic Market Size by Region (2020-2025)

2.2.3 Patent Drug Forecasted Market Size by Region (2026-2031)

2.3 Patent Drug Market Dynamics

2.3.1 Patent Drug Industry Trends

2.3.2 Patent Drug Market Drivers

2.3.3 Patent Drug Market Challenges

2.3.4 Patent Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Patent Drug Players by Revenue

3.1.1 Global Top Patent Drug Players by Revenue (2020-2025)

3.1.2 Global Patent Drug Revenue Market Share by Players (2020-2025)

3.2 Global Patent Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Patent Drug Revenue

3.4 Global Patent Drug Market Concentration Ratio

3.4.1 Global Patent Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Patent Drug Revenue in 2024

3.5 Global Key Players of Patent Drug Head office and Area Served

3.6 Global Key Players of Patent Drug, Product and Application

3.7 Global Key Players of Patent Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Patent Drug Breakdown Data by Type

4.1 Global Patent Drug Historic Market Size by Type (2020-2025)

4.2 Global Patent Drug Forecasted Market Size by Type (2026-2031)

5 Patent Drug Breakdown Data by Application

5.1 Global Patent Drug Historic Market Size by Application (2020-2025)

5.2 Global Patent Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Patent Drug Market Size (2020-2031)

6.2 North America Patent Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Patent Drug Market Size by Country (2020-2025)

6.4 North America Patent Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Patent Drug Market Size (2020-2031)

7.2 Europe Patent Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Patent Drug Market Size by Country (2020-2025)

7.4 Europe Patent Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Patent Drug Market Size (2020-2031)

8.2 Asia-Pacific Patent Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Patent Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Patent Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Patent Drug Market Size (2020-2031)

9.2 Latin America Patent Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Patent Drug Market Size by Country (2020-2025)

9.4 Latin America Patent Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Patent Drug Market Size (2020-2031)

10.2 Middle East & Africa Patent Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Patent Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Patent Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Patent Drug Introduction

11.1.4 Pfizer Revenue in Patent Drug Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Patent Drug Introduction

11.2.4 Roche Revenue in Patent Drug Business (2020-2025)

11.2.5 Roche Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Patent Drug Introduction

11.3.4 Sanofi Revenue in Patent Drug Business (2020-2025)

11.3.5 Sanofi Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Patent Drug Introduction

11.4.4 Johnson & Johnson Revenue in Patent Drug Business (2020-2025)

11.4.5 Johnson & Johnson Recent Development

11.5 Merck & Co. (MSD)

11.5.1 Merck & Co. (MSD) Company Details

11.5.2 Merck & Co. (MSD) Business Overview

11.5.3 Merck & Co. (MSD) Patent Drug Introduction

11.5.4 Merck & Co. (MSD) Revenue in Patent Drug Business (2020-2025)

11.5.5 Merck & Co. (MSD) Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Patent Drug Introduction

11.6.4 Novartis Revenue in Patent Drug Business (2020-2025)

11.6.5 Novartis Recent Development

11.7 AbbVie

11.7.1 AbbVie Company Details

11.7.2 AbbVie Business Overview

11.7.3 AbbVie Patent Drug Introduction

11.7.4 AbbVie Revenue in Patent Drug Business (2020-2025)

11.7.5 AbbVie Recent Development

11.8 Gilead Sciences

11.8.1 Gilead Sciences Company Details

11.8.2 Gilead Sciences Business Overview

11.8.3 Gilead Sciences Patent Drug Introduction

11.8.4 Gilead Sciences Revenue in Patent Drug Business (2020-2025)

11.8.5 Gilead Sciences Recent Development

11.9 GlaxoSmithKline (GSK)

11.9.1 GlaxoSmithKline (GSK) Company Details

11.9.2 GlaxoSmithKline (GSK) Business Overview

11.9.3 GlaxoSmithKline (GSK) Patent Drug Introduction

11.9.4 GlaxoSmithKline (GSK) Revenue in Patent Drug Business (2020-2025)

11.9.5 GlaxoSmithKline (GSK) Recent Development

11.10 Amgen

11.10.1 Amgen Company Details

11.10.2 Amgen Business Overview

11.10.3 Amgen Patent Drug Introduction

11.10.4 Amgen Revenue in Patent Drug Business (2020-2025)

11.10.5 Amgen Recent Development

11.11 AstraZeneca

11.11.1 AstraZeneca Company Details

11.11.2 AstraZeneca Business Overview

11.11.3 AstraZeneca Patent Drug Introduction

11.11.4 AstraZeneca Revenue in Patent Drug Business (2020-2025)

11.11.5 AstraZeneca Recent Development

11.12 Bristol-Myers Squibb

11.12.1 Bristol-Myers Squibb Company Details

11.12.2 Bristol-Myers Squibb Business Overview

11.12.3 Bristol-Myers Squibb Patent Drug Introduction

11.12.4 Bristol-Myers Squibb Revenue in Patent Drug Business (2020-2025)

11.12.5 Bristol-Myers Squibb Recent Development

11.13 Eli Lilly

11.13.1 Eli Lilly Company Details

11.13.2 Eli Lilly Business Overview

11.13.3 Eli Lilly Patent Drug Introduction

11.13.4 Eli Lilly Revenue in Patent Drug Business (2020-2025)

11.13.5 Eli Lilly Recent Development

11.14 Teva

11.14.1 Teva Company Details

11.14.2 Teva Business Overview

11.14.3 Teva Patent Drug Introduction

11.14.4 Teva Revenue in Patent Drug Business (2020-2025)

11.14.5 Teva Recent Development

11.15 Bayer

11.15.1 Bayer Company Details

11.15.2 Bayer Business Overview

11.15.3 Bayer Patent Drug Introduction

11.15.4 Bayer Revenue in Patent Drug Business (2020-2025)

11.15.5 Bayer Recent Development

11.16 Novo Nordisk

11.16.1 Novo Nordisk Company Details

11.16.2 Novo Nordisk Business Overview

11.16.3 Novo Nordisk Patent Drug Introduction

11.16.4 Novo Nordisk Revenue in Patent Drug Business (2020-2025)

11.16.5 Novo Nordisk Recent Development

11.17 AbbVie

11.17.1 AbbVie Company Details

11.17.2 AbbVie Business Overview

11.17.3 AbbVie Patent Drug Introduction

11.17.4 AbbVie Revenue in Patent Drug Business (2020-2025)

11.17.5 AbbVie Recent Development

11.18 Takeda

11.18.1 Takeda Company Details

11.18.2 Takeda Business Overview

11.18.3 Takeda Patent Drug Introduction

11.18.4 Takeda Revenue in Patent Drug Business (2020-2025)

11.18.5 Takeda Recent Development

11.19 Boehringer Ingelheim

11.19.1 Boehringer Ingelheim Company Details

11.19.2 Boehringer Ingelheim Business Overview

11.19.3 Boehringer Ingelheim Patent Drug Introduction

11.19.4 Boehringer Ingelheim Revenue in Patent Drug Business (2020-2025)

11.19.5 Boehringer Ingelheim Recent Development

11.20 Takeda

11.20.1 Takeda Company Details

11.20.2 Takeda Business Overview

11.20.3 Takeda Patent Drug Introduction

11.20.4 Takeda Revenue in Patent Drug Business (2020-2025)

11.20.5 Takeda Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GlaxoSmithKline(GSK )

Eli Lilly

Novartis

List of Tables

Table 1. Global Patent Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oral

Table 3. Key Players of Injection

Table 4. Key Players of Other

Table 5. Global Patent Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Patent Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Patent Drug Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Patent Drug Market Share by Region (2020-2025)

Table 9. Global Patent Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Patent Drug Market Share by Region (2026-2031)

Table 11. Patent Drug Market Trends

Table 12. Patent Drug Market Drivers

Table 13. Patent Drug Market Challenges

Table 14. Patent Drug Market Restraints

Table 15. Global Patent Drug Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Patent Drug Market Share by Players (2020-2025)

Table 17. Global Top Patent Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Drug as of 2024)

Table 18. Ranking of Global Top Patent Drug Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Patent Drug Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Patent Drug, Headquarters and Area Served

Table 21. Global Key Players of Patent Drug, Product and Application

Table 22. Global Key Players of Patent Drug, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Patent Drug Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Patent Drug Revenue Market Share by Type (2020-2025)

Table 26. Global Patent Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Patent Drug Revenue Market Share by Type (2026-2031)

Table 28. Global Patent Drug Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Patent Drug Revenue Market Share by Application (2020-2025)

Table 30. Global Patent Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Patent Drug Revenue Market Share by Application (2026-2031)

Table 32. North America Patent Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Patent Drug Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Patent Drug Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Patent Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Patent Drug Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Patent Drug Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Patent Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Patent Drug Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Patent Drug Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Patent Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Patent Drug Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Patent Drug Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Patent Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Patent Drug Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Patent Drug Market Size by Country (2026-2031) & (US$ Million)

Table 47. Pfizer Company Details

Table 48. Pfizer Business Overview

Table 49. Pfizer Patent Drug Product

Table 50. Pfizer Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Roche Company Details

Table 53. Roche Business Overview

Table 54. Roche Patent Drug Product

Table 55. Roche Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 56. Roche Recent Development

Table 57. Sanofi Company Details

Table 58. Sanofi Business Overview

Table 59. Sanofi Patent Drug Product

Table 60. Sanofi Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 61. Sanofi Recent Development

Table 62. Johnson & Johnson Company Details

Table 63. Johnson & Johnson Business Overview

Table 64. Johnson & Johnson Patent Drug Product

Table 65. Johnson & Johnson Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 66. Johnson & Johnson Recent Development

Table 67. Merck & Co. (MSD) Company Details

Table 68. Merck & Co. (MSD) Business Overview

Table 69. Merck & Co. (MSD) Patent Drug Product

Table 70. Merck & Co. (MSD) Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 71. Merck & Co. (MSD) Recent Development

Table 72. Novartis Company Details

Table 73. Novartis Business Overview

Table 74. Novartis Patent Drug Product

Table 75. Novartis Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 76. Novartis Recent Development

Table 77. AbbVie Company Details

Table 78. AbbVie Business Overview

Table 79. AbbVie Patent Drug Product

Table 80. AbbVie Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 81. AbbVie Recent Development

Table 82. Gilead Sciences Company Details

Table 83. Gilead Sciences Business Overview

Table 84. Gilead Sciences Patent Drug Product

Table 85. Gilead Sciences Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 86. Gilead Sciences Recent Development

Table 87. GlaxoSmithKline (GSK) Company Details

Table 88. GlaxoSmithKline (GSK) Business Overview

Table 89. GlaxoSmithKline (GSK) Patent Drug Product

Table 90. GlaxoSmithKline (GSK) Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 91. GlaxoSmithKline (GSK) Recent Development

Table 92. Amgen Company Details

Table 93. Amgen Business Overview

Table 94. Amgen Patent Drug Product

Table 95. Amgen Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 96. Amgen Recent Development

Table 97. AstraZeneca Company Details

Table 98. AstraZeneca Business Overview

Table 99. AstraZeneca Patent Drug Product

Table 100. AstraZeneca Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 101. AstraZeneca Recent Development

Table 102. Bristol-Myers Squibb Company Details

Table 103. Bristol-Myers Squibb Business Overview

Table 104. Bristol-Myers Squibb Patent Drug Product

Table 105. Bristol-Myers Squibb Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 106. Bristol-Myers Squibb Recent Development

Table 107. Eli Lilly Company Details

Table 108. Eli Lilly Business Overview

Table 109. Eli Lilly Patent Drug Product

Table 110. Eli Lilly Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 111. Eli Lilly Recent Development

Table 112. Teva Company Details

Table 113. Teva Business Overview

Table 114. Teva Patent Drug Product

Table 115. Teva Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 116. Teva Recent Development

Table 117. Bayer Company Details

Table 118. Bayer Business Overview

Table 119. Bayer Patent Drug Product

Table 120. Bayer Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 121. Bayer Recent Development

Table 122. Novo Nordisk Company Details

Table 123. Novo Nordisk Business Overview

Table 124. Novo Nordisk Patent Drug Product

Table 125. Novo Nordisk Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 126. Novo Nordisk Recent Development

Table 127. AbbVie Company Details

Table 128. AbbVie Business Overview

Table 129. AbbVie Patent Drug Product

Table 130. AbbVie Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 131. AbbVie Recent Development

Table 132. Takeda Company Details

Table 133. Takeda Business Overview

Table 134. Takeda Patent Drug Product

Table 135. Takeda Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 136. Takeda Recent Development

Table 137. Boehringer Ingelheim Company Details

Table 138. Boehringer Ingelheim Business Overview

Table 139. Boehringer Ingelheim Patent Drug Product

Table 140. Boehringer Ingelheim Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 141. Boehringer Ingelheim Recent Development

Table 142. Takeda Company Details

Table 143. Takeda Business Overview

Table 144. Takeda Patent Drug Product

Table 145. Takeda Revenue in Patent Drug Business (2020-2025) & (US$ Million)

Table 146. Takeda Recent Development

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

Table 150. Authors List of This Report

List of Figures

Figure 1. Patent Drug Picture

Figure 2. Global Patent Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Patent Drug Market Share by Type: 2024 VS 2031

Figure 4. Oral Features

Figure 5. Injection Features

Figure 6. Other Features

Figure 7. Global Patent Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Patent Drug Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Retail Pharmacy Case Studies

Figure 11. Patent Drug Report Years Considered

Figure 12. Global Patent Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Patent Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Patent Drug Market Share by Region: 2024 VS 2031

Figure 15. Global Patent Drug Market Share by Players in 2024

Figure 16. Global Top Patent Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Drug as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Patent Drug Revenue in 2024

Figure 18. North America Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Patent Drug Market Share by Country (2020-2031)

Figure 20. United States Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Patent Drug Market Share by Country (2020-2031)

Figure 24. Germany Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Patent Drug Market Share by Region (2020-2031)

Figure 32. China Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Patent Drug Market Share by Country (2020-2031)

Figure 40. Mexico Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Patent Drug Market Share by Country (2020-2031)

Figure 44. Turkey Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Patent Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Pfizer Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 48. Roche Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 49. Sanofi Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 50. Johnson & Johnson Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 51. Merck & Co. (MSD) Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 52. Novartis Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 53. AbbVie Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 54. Gilead Sciences Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 55. GlaxoSmithKline (GSK) Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 56. Amgen Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 57. AstraZeneca Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 59. Eli Lilly Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 60. Teva Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 61. Bayer Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 62. Novo Nordisk Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 63. AbbVie Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 64. Takeda Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 65. Boehringer Ingelheim Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 66. Takeda Revenue Growth Rate in Patent Drug Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Lawyer Referral Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0N19345

Tue Feb 18 00:00:00 UTC 2025

Add to Cart

Global Medical Negligence Claim Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34G12067

Thu Feb 13 00:00:00 UTC 2025

Add to Cart

Global Patent Drug Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19W12732

Thu Feb 13 00:00:00 UTC 2025

Add to Cart

Global Traffic Accident Liability Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2T11747

Fri Feb 07 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions